Correlation Between Protagonist Therapeutics and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both Protagonist Therapeutics and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagonist Therapeutics and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protagonist Therapeutics and Molecular Partners AG, you can compare the effects of market volatilities on Protagonist Therapeutics and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagonist Therapeutics with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagonist Therapeutics and Molecular Partners.
Diversification Opportunities for Protagonist Therapeutics and Molecular Partners
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Protagonist and Molecular is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Protagonist Therapeutics and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Protagonist Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagonist Therapeutics are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Protagonist Therapeutics i.e., Protagonist Therapeutics and Molecular Partners go up and down completely randomly.
Pair Corralation between Protagonist Therapeutics and Molecular Partners
Given the investment horizon of 90 days Protagonist Therapeutics is expected to generate 1.04 times more return on investment than Molecular Partners. However, Protagonist Therapeutics is 1.04 times more volatile than Molecular Partners AG. It trades about 0.03 of its potential returns per unit of risk. Molecular Partners AG is currently generating about -0.13 per unit of risk. If you would invest 4,039 in Protagonist Therapeutics on September 19, 2024 and sell it today you would earn a total of 30.00 from holding Protagonist Therapeutics or generate 0.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Protagonist Therapeutics vs. Molecular Partners AG
Performance |
| Timeline |
| Protagonist Therapeutics |
| Molecular Partners |
Protagonist Therapeutics and Molecular Partners Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protagonist Therapeutics and Molecular Partners
The main advantage of trading using opposite Protagonist Therapeutics and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagonist Therapeutics position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.| Protagonist Therapeutics vs. Revolution Medicines | Protagonist Therapeutics vs. Akero Therapeutics | Protagonist Therapeutics vs. Avidity Biosciences | Protagonist Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |